Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation

Retinal Ganglion Cell Gene Therapy and Visual System Repair

(2011) Mats Hellstrom et al.   CURRENT GENE THERAPY

Phosphorylation and Cleavage of the Family of Collapsin Response Mediator Proteins May Play a Central Role in Neurodegeneration after CNS Trauma

(2011) Kasra Taghian et al.   JOURNAL OF NEUROTRAUMA

Oligodendrocyte PTEN is required for myelin and axonal integrity, not remyelination

(2010) Emily P. Harrington et al.   ANNALS OF NEUROLOGY

Anti-Nogo on the go: from animal models to a clinical trial

(2010) Björn Zörner et al.   Annals of the New York Academy of Sciences

Signalling mechanisms regulating axonal branching in vivo

(2010) Hannes Schmidt et al.   BIOESSAYS

Novel Therapeutic Targets for Axonal Degeneration in Multiple Sclerosis

(2010) Steven Petratos et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Emerging Repair, Regeneration, and Translational Research Advances for Spinal Cord Injury

(2010) Brian K. Kwon et al.   SPINE

Involvement of WAVE Accumulation in Aβ/APP Pathology-Dependent Tangle Modification in Alzheimer’s Disease

(2009) Kazuyuki Takata et al.   AMERICAN JOURNAL OF PATHOLOGY

Silencing Nogo-A promotes functional recovery in demyelinating disease

(2009) Yuhong Yang et al.   ANNALS OF NEUROLOGY

Myelin regulates immune cell adhesion and motility

(2009) Madeline Pool et al.   EXPERIMENTAL NEUROLOGY

CRMP-2 directly binds to cytoplasmic dynein and interferes with its activity

(2009) Nariko Arimura et al.   JOURNAL OF NEUROCHEMISTRY

Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis

(2008) J. M. Anderson et al.   BRAIN